Table 3.
Best Overall Tumor Response in the Efficacy Population (n = 38)
| Tumor response | Value |
|---|---|
| RECIST version 1.0 | |
| Complete response | 1 (3.4%) |
| Partial response | 20 (69.0%) |
| Stable disease | 3 (10.3%) |
| Progressive disease | 5 (17.2%) |
| Not assessed/missing | 9 |
| Immune-related response criteria | |
| Complete response | 2 (6.1%) |
| Partial response | 26 (78.8%) |
| Stable disease | 5 (15.2%) |
| Progressive disease | 0 |
| Not assessed/missing | 5 |
RECIST, Response Evaluation Criteria in Solid Tumors.